Bacteriological and serological control of H. pylori infection in patients with chronic gastritis and duodenal ulcer: Results of four-year follow-up;Wyniki czteroletniej kontroli bakteriologicznej i serologicznej zakażenia H. pylori u chorych z przewlekłym zapaleniem żoła̧dka i choroba̧ wrzodowa̧ dwunastnicy

Gastroenterologia Polska

Volumn 9, Issue 4, 2002, Pages 281-286

  Gościniak, Grazyna ^a   Poniewierka, Elzbieta ^b   Przondo Mordarska, Anna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Kat Klinika Gastroenterologii AM   (Poland)

Author keywords

Antibodies; Helicobacter pylori; Reinfection

Indexed keywords

AMOXICILLIN; COLLOIDAL BISMUTH COMPOUND; ERYTHROMYCIN; IMMUNOGLOBULIN G; METRONIDAZOLE;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; CHRONIC GASTRITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DUODENUM ULCER; ENZYME LINKED IMMUNOSORBENT ASSAY; ERADICATION THERAPY; FEMALE; FOLLOW UP; GRAM STAINING; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; REINFECTION; SEROLOGY; STOMACH MUCOSA; TREATMENT OUTCOME; ULTRACENTRIFUGE;

EID: 1442313526     PISSN: 12329886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Andersen L.P., Espersen F.: Immunoglobulin G antibodies to Helicobacter pylori in patients with dyspeptic symptoms investigated by the Western immunoblot technique. J. Clin. Microbiol., 1992, 30, 1743-1751.
2. Andersen L.P., Rosenstock S.J., Bonnevie O., Jorgensen T.: Seroprevalence of immunoglobulin G, M, and A antibodies to Helicobacter pylori in an unselected Danish population. Am. J. Epidemiol., 1996, 143, 1157-1164.
3. Bell G.D., Powell K.U.: Helicobacter pylori reinfection after apparent eradication - The Ipswich experience. Scand. J. Gastroenterol., 1996, 31, supl. 215, 96-104.
4. Bermejo F., Boixeda D., Gisbert J.P., Sanz J.M., Canton R., Defarges V., Martin-de-Argila C.: Concordance between noninvasive tests in detecting Helicobacter pylori and potential use of serology for monitoring eradication in gastric ulcer. J. Clin. Gastroenterol., 2000, 31, 137-141.
5. Cutler A., Schubert A., Schubert T.: Role of Helicobacter pylori serology in evaluating treatment success. Dig. Dis. Sci., 1993, 38, 2262-2266.
6. Cutler A.F., Vajravel M., Prasad V.M., Santogade P.: Four-year trends in Helicobacter pylori IgG serology following successful eradication. Am. J. Med., 1998, 105, 18-20.
7. Dzierzanowska D., Gzyl A., Rozynek E., Augustynowicz E., Wojda U., Celińska-Cedro D., Sankowska M., Wadstrom T.: PCR for identification and typing of Helicobacter pylori isolated from children. J. Physiol. Pharmacol., 1996, 47, 101-114.
8. Dzierzanowska D., Murawska B., Patzer J., Gzyl A.: Application of molecular techniques for diagnosis of Helicobacter pylori infections. Microbiol. Med., 1998, 15, 48-52.
9. Gisbert J.P., Blanco M., Benito L.M., Pajares J.M.: Value of quantitative serology for confirmation of Helicobacter pylori eradication: An 18-month follow-up study. Clin. Infect. Dis., 2000, 30, 976-980.
10. Glupczynski Y., Burette A., Goossens H., DePraz C., Butzler JP.: Effect of antimicrobial therapy on the specific serological response to Helicobacter pylori infection. Eur. J. Clin Microbiol. Infect. Dis., 1992, 11, 583-588.
11. Gościniak G.: IgG and IgA antibodies in Helicobacter pylori infections. Zbl. Bakt., 1997, 286, 494-502.
12. Gościniak G., Matysiak-Budnik T., Przondo-Mordarska A.: Evaluation of three serological tests for the detection of Helicobacter pylori associated infection. Arch. Immunol. Ther. Exp. 1993, 41, 315-319.
13. Gościniak G., Przondo-Mordarska A., Matysiak-Budnik T., Knapik Z.: Serological examinations in patients with Helicobacter pylori infections. Arch. Immunol. Ther. Exp., 1993, 41, 309-313.
14. Gürel S., Besisk F., Demir K., Mungan Z., Kaymakoglu S., Boztas G., Cakaloglu Y., Yeginsü O., Ökten A.: After the eradication of Helicobacter pylori infection, relapse is a serious problem in Turkey. J. Clin. Gastroenterol., 1999, 28, 241-244.
15. Jarczyk G., Jarczyk J., Raczyńska A., Jȩdrzejczyk W., Nowacka B., Przybylska A., Donderski W.: Eradykacja H. pylori i zmniejszenie wskaźnika nawrotu wrzodu trawiennego 12 miesiȩcy po zastosowaniu terapii potrójnej. Gastroenterol. Pol., 1997, 4, 53-59.
16. Kato S., Furuyama N., Ozawa K., Ohnuma K., Iinuma K.: Long-term follow-up study of serum immunoglobulin G and immunoglobulin A antibodies after Helicobacter pylori eradication. Pediatrics, 1999, 104, e22.
17. Kosunen T.U., Seppälä K., Sarna S., Sipponen P.: Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet, 1992, 339, 893-895.
18. Logan R.P.H.: Adherence of H. pylori. Aliment. Pharmacol. Ther., 1996, 10, supl. 1, 3-15.
19. Matysiak-Budnik T., Mégraud F.: Epidemiology of Helicobacter pylori infection with special reference to professional risk. J. Physiol. Pharmacol., 1997, 48, supl. 4, 3-17.
20. Midolo P.D., Dakic B., Nicholson L., Lambert J.R., Lin S., Russell E.G.: Use of a dry latex agglutination test to measure eradication of Helicobacter pylori infection. J. Gastroenterol. Hepatol., 2000, 15, 254-256.
21. Muszyński J., Dzierżanowska D., Siemińska J., Vogt E., Ehrmann A., Górnicka B., Czetwertyńska M.: Seroepidemiologia zakażenia Helicobacter pylori. Gastroenterol. Pol., 1996, 3, 35-43.
22. Perez-Perez G.I., Cutler A.F., Blaser M.J.: Value of serology as a noninvasive method for evaluating the efficacy of treatment of Helicobacter pylori infection. Clin. Infect. Dis., 1997, 25, 1038-1043.
23. Rollan A., Giancaspero R., Fuster F., Acevedo C., Figueroa C., Hola K., Schulz M., Duarte I.: The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country. Am. J. Gastroenterol., 2000, 1, 50-56.
24. Sörberg M., Engstrand L., Ström M., Jönsson KA., Jörbeck H., Granström M.: The diagnostic value of enzyme immunoassay and immunoblot in monitoring eradication of Helicobacter pylori. Scand. J. Infect. Dis., 1997, 29, 147-151.
25. Stanowisko Polskiej Grupy Roboczej dotycza̧ce zakażenia Helicobacter pylori (1997 r.). Gastroenterol. Pol., 1997, 4, 635-640.
26. Wang W., Chen C., Jan C., Chen L., Perng D., Lin S., Lui C.: Long-term follow up and serological study after triple therapy of Helicobacter pylori associated duodenal ulcer. Am. J. Gastroenterol., 1994, 89, 1793-1795.
27. Wytyczne opracowane przez Grupȩ Robocza̧ Polskiego Towarzystwa Gastroenterologii. Consensus. Postȩpowanie w zakażeniu Helicobacter pylori (rok 2000). Wytyczne opracowane przez Grupȩ Robocza̧ Polskiego Towarzystwa Gastroenterologii. Gastroenterol. Pol., 2001, 8, 11-18
28. Yunoki N., Yokota K., Mizuno M., Kawahara Y., Adachi M., Okada H., Hayashi S., Hirai Y., Oguma K., Tsuji T.: Antibody to heat shock protein can be used for early serological monitoring of Helicobacter pylori eradication treatment. Clin. Diagn. Lab. Immunol., 2000, 7, 574-577.